Ngapas, Acmad N.

HRN: 28-10-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/06/2025
12/12/2025
IVTT
2.25 G
Q6
Cap HR
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: